ELAB
HEALTHCAREElevai Labs, Inc. Common Stock
AI Insight
What's Moving ELAB Today?
No stock-specific AI insight has been generated for ELAB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.29$267.12
$1.32
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-150.06
Dividend Yield—
Dividend / Share—
ROE-107.9%
Profit Margin—
Debt / Equity—
Trading
Volume316K
Avg Volume (10D)—
Shares Outstanding4.5M
ELAB News
26 articles- NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment MarketsYahoo Finance·Jun 18, 2026
- PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply ChainsYahoo Finance·Jun 10, 2026
- NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime ApplicationsYahoo! Finance Canada·Jun 8, 2026
- [Form 4] PMGC Holdings Inc. Insider Trading ActivityStock Titan·Jun 2, 2026
- PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor MarketsYahoo Finance·Jun 1, 2026
- GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc.Yahoo Finance·May 18, 2026
- PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-YearYahoo Finance·May 15, 2026
- PMGC Holdings: Aerospace Manufacturing Platform Expands With A&B Aerospace AcquisitionPulse 2.0·May 14, 2026
- PMGC Grabs Precision Parts Maker Serving Boeing, HoneywellYahoo Finance·May 13, 2026
- PMGC Holdings (NASDAQ: ELAB) Acquires A&B Aerospace, Inc.Yahoo Finance·May 13, 2026
- UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological DisordersYahoo Finance·Apr 28, 2026
- NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in HumansYahoo Finance·Apr 28, 2026
- NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft SystemsYahoo Finance·Apr 23, 2026
- Univest Securities, LLC Announces a $40 Million Equity Line Facility for its Client PMGC Holdings, Inc. (NASDAQ: ELAB)GlobeNewswire Inc.·Apr 21, 2026
- SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.Yahoo Finance·Apr 21, 2026
- PMGC Holdings, Inc. (Nasdaq: ELAB) Secures $40 Million Equity Purchase Facility Agreement: Announces Ability To Accelerate M&A Strategy Currently Focused on Acquiring Aerospace and Defense Manufacturing CompaniesYahoo Finance·Apr 17, 2026
- NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant BiosciencesYahoo Finance·Apr 13, 2026
- Pacific Sun Packaging to Showcase Solutions at ITAD Europe 2026, Targeting Global Market ExpansionYahoo Finance·Apr 10, 2026
- AGA Precision Systems Signs Second Long-Term Supply Agreement to Manufacture Aerospace and Defense Components for a Tier 1 FirmYahoo Finance·Apr 9, 2026
- Why PMGC Shares Are Rocketing On Wednesday?Benzinga·Apr 8, 2026
- PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition StrategyYahoo Finance·Apr 8, 2026
- Why Are PMGC Shares Tumbling On Tuesday?Benzinga·Apr 7, 2026
- What's Going On With PMGC Stock Monday?Benzinga·Apr 6, 2026
- NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial ApplicationsYahoo Finance·Apr 6, 2026
- PMGC Holdings Inc. Announces the Formation of New Subsidiary, NorthStrive Defense Tech to Target High-Growth Defense, Drone and Autonomous Systems SectorYahoo Finance·Apr 2, 2026
- PMGC Holdings Dips 50% After Massive Rally: What's Going On With ELAB StockBenzinga·Apr 2, 2026
All 26 articles loaded
Price Data
Open$1.30
Previous Close$1.35
Day High$1.35
Day Low$1.29
52 Week High$267.12
52 Week Low$1.29
52-Week Range
$1.29$267.12
$1.32
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-150.06
Dividend Yield—
Dividend / Share—
ROE-107.9%
Profit Margin—
Debt / Equity—
Trading
Volume316K
Avg Volume (10D)—
Shares Outstanding4.5M
About Elevai Labs, Inc. Common Stock
Elevai Labs, Inc. (Ticker: ELAB) is a cutting-edge technology company specializing in artificial intelligence and machine learning solutions, primarily serving the healthcare and finance sectors. With a focus on sophisticated data analytics, Elevai Labs equips organizations with the tools to derive actionable insights from complex datasets, driving operational efficiencies and informed decision-making. Positioned strategically in a rapidly evolving tech landscape, the company is well-equipped to capitalize on emerging market trends, creating significant value for its clients and stakeholders. Elevai Labs' dedication to advancing AI technologies establishes it as a key player with promising potential for sustainable growth and competitive differentiation.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—